{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:59:49Z","timestamp":1792015189202,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2020M683128"],"award-info":[{"award-number":["2020M683128"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100648"],"award-info":[{"award-number":["82100648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870404"],"award-info":[{"award-number":["81870404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670518"],"award-info":[{"award-number":["81670518"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170392"],"award-info":[{"award-number":["81170392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005198","name":"Chinese Foundation for Hepatitis Prevention and Control","doi-asserted-by":"publisher","award":["TQGB20140083"],"award-info":[{"award-number":["TQGB20140083"]}],"id":[{"id":"10.13039\/501100005198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2019496"],"award-info":[{"award-number":["A2019496"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>As the nonalcoholic fatty liver disease (NAFLD) epidemic matures, understanding how metabolic changes in NAFLD development vary over the age distribution is important to guide precise prevention. We aimed to clarify metabolic trends in age-specific NAFLD incidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a 4-year longitudinal retrospective cohort study enrolling 10,240 consecutive healthy individuals who received annual physical examination during 2012\u20132019. Baseline and dynamic changes in metabolism and hepatic steatosis determined with ultrasound were collected and analyzed stratified by age into the following groups: 20\u201334, 35\u201349, 50\u201364, and over 65\u00a0years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 1701 incident NAFLD participants (16.6%) were identified. Adjusted Cox regression analysis showed that the baseline and increased body mass index were the main risk factors for NAFLD in people \u2264\u200965\u00a0years old. Baseline high-density lipoprotein (HR\u2009=\u20090.56; 95% CI 0.39\u20130.78) was a protective factor for newly onset NAFLD in the 50-to-64-year-old group, while baseline SBP (HR\u2009=\u20091.03; 95% CI 1.01\u20131.05), baseline uric acid (HR\u2009=\u20091.04; 95% CI 1.01\u20131.07), triglyceride increase (HR\u2009=\u20094.76; 95% CI 3.69\u20136.14), fasting blood glucose increase (HR\u2009=\u20091.32; 95% CI 1.06\u20131.65) were independently associated with incident NAFLD in over-65-year-old group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>NAFLD incidence attributable to potentially metabolic risk factors varied substantially across age groups in a cohort of Chinese people. The adoption of age targeted metabolic prevention strategies might reduce the burden of NAFLD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-022-00930-w","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T14:03:18Z","timestamp":1669644198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes"],"prefix":"10.1186","volume":"14","author":[{"given":"Yansong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongcai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"issue":"1","key":"930_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"7","key":"930_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/gut.2009.205088","volume":"59","author":"VW Wong","year":"2010","unstructured":"Wong VW, Wong GL, Choi PC, Chan AW, Li MA, Chan HY, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut. 2010;59(7):969\u201374.","journal-title":"Gut"},{"issue":"5","key":"930_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou BY, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389\u201398.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"930_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274\u201385.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"930_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.hbpd.2021.08.004","volume":"20","author":"YX Lin","year":"2021","unstructured":"Lin YX, Liu X, Cen C, Li X, Liu JM, Ming ZY, et al. Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: an extended study. Hepatobiliary Pancreat Dis Int. 2021;20(5):409\u201315.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"4","key":"930_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/nutrit\/nuv052","volume":"74","author":"D Meynial-Denis","year":"2016","unstructured":"Meynial-Denis D. Glutamine metabolism in advanced age. Nutr Rev. 2016;74(4):225\u201336.","journal-title":"Nutr Rev"},{"issue":"655","key":"930_CR7","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1126\/science.abe5017","volume":"373","author":"H Pontzer","year":"2021","unstructured":"Pontzer H, Yamada Y, Sagayama H, Ainslie PN, Andersen LF, Arab L, et al. Daily energy expenditure through the human life course. Science. 2021;373(655):808\u201312.","journal-title":"Science"},{"issue":"6","key":"930_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1440-1746.2007.05042.x","volume":"22","author":"DN Amarapurkar","year":"2007","unstructured":"Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL, et al. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22(6):788\u201393.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"930_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol. 2018;69(4):896\u2013904.","journal-title":"J Hepatol"},{"issue":"5","key":"930_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3748\/wjg.v9.i5.1106","volume":"9","author":"L Shen","year":"2003","unstructured":"Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol. 2003;9(5):1106\u201310.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"930_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12072-020-10023-3","volume":"14","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zheng Q, Zou B, Yeo YH, Li X, Li J, et al. The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. Hepatol Int. 2020;14(2):259\u201369.","journal-title":"Hepatol Int"},{"issue":"4","key":"930_CR12","first-page":"347","volume":"16","author":"H Yan","year":"2007","unstructured":"Yan H, Lu XF, Luo JY, Zhou XY. Epidemiological analysis of alcoholic and non-alcoholic fatty liver in Shanxi and Gansu province. Chin J Gastroenterol Hepatol. 2007;16(4):347\u201353.","journal-title":"Chin J Gastroenterol Hepatol"},{"issue":"2","key":"930_CR13","first-page":"379","volume":"37","author":"XD Shi","year":"2011","unstructured":"Shi XD, Wei Q, He SM, Tao YC, Sun J, Niu JQ. Epidemiology and analysis on risk factors of non-infectious chronic diseases in adults in northeast China. J Jilin Univ (Medicine Edition). 2011;37(2):379\u201384.","journal-title":"J Jilin Univ (Medicine Edition)"},{"issue":"4","key":"930_CR14","first-page":"383","volume":"25","author":"L Shi","year":"2012","unstructured":"Shi L, Liu ZW, Li Y, Gong C, Zhang H, Song LJ, et al. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle\/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci. 2012;25(4):383\u201391.","journal-title":"Biomed Environ Sci"},{"issue":"10","key":"930_CR15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"930_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"ZH Lin","year":"2011","unstructured":"Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase\u2013to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53(3):726\u201336.","journal-title":"Hepatology"},{"key":"930_CR17","unstructured":"National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association, Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. Zhonghua Gan Zang Bing Za Zhi. 2018;26(3):195\u2013203."},{"issue":"1","key":"930_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","volume":"137","author":"D Prati","year":"2002","unstructured":"Prati D, Taioli E, Zanella A, Torre ED, Butelli S, Vecchio ED, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1\u201310.","journal-title":"Ann Intern Med"},{"issue":"1","key":"930_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"5","key":"930_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S1474-4422(21)00042-9","volume":"20","author":"HW Westeneng","year":"2021","unstructured":"Westeneng HW, Veenhuijzen K, Spek RA, Peters S, Visser AE, Rheenen W, et al. Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study. Lancet Neurol. 2021;20(5):373\u201384.","journal-title":"Lancet Neurol"},{"issue":"1","key":"930_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jhep.2014.10.023","volume":"62","author":"G Marchesini","year":"2015","unstructured":"Marchesini G, Mazzotti A. NAFLD incidence and remission: only a matter of weight gain and weight loss? J Hepatol. 2015;62(1):15\u20137.","journal-title":"J Hepatol"},{"key":"930_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.891963","volume":"9","author":"W Wu","year":"2022","unstructured":"Wu W, Feng A, Ma W, et al. Worldwide long-term trends in the incidence of nonalcoholic fatty liver disease during 1990\u20132019: a joinpoint and age-period-cohort analysis. Front Cardiovasc Med. 2022;9: 891963.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"930_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266505","volume":"17","author":"EC Aneni","year":"2022","unstructured":"Aneni EC, Saeed GJ, Bittencourt MS, et al. Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: a longitudinal study comparing lean and non-lean individuals. PLoS ONE. 2022;17(4): e0266505.","journal-title":"PLoS ONE"},{"issue":"5","key":"930_CR24","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Feng Zhou F, Wang W, et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology. 2020;71(5):1851\u201364.","journal-title":"Hepatology"},{"key":"930_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397.","journal-title":"Metabolism"},{"issue":"5","key":"930_CR26","first-page":"510","volume":"40","author":"M Zhou","year":"2019","unstructured":"Zhou M, Zhu NB, Yu CQ, Du HD, Lv J, Guo Y, et al. Analysis on adulthood weight change in adults in China. Chin J Epidemiol. 2019;40(5):510\u20134.","journal-title":"Chin J Epidemiol"},{"issue":"8","key":"930_CR27","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/jgh.14105","volume":"33","author":"J Wang","year":"2018","unstructured":"Wang J, Ma L, Chen S, Xu L, Miao M, Yu C, et al. Risk for the development of non-alcoholic fatty liver disease: a prospective study. J Gastroenterol Hepatol. 2018;33(8):1518\u201323.","journal-title":"J Gastroenterol Hepatol"},{"key":"930_CR28","first-page":"546","volume":"43","author":"XY Yu","year":"2014","unstructured":"Yu XY, Zhao Y, Song X, Song Z. The association between body mass index and non-alcoholic fatty liver disease. J Zhejiang Univ (Medical Sciences). 2014;43:546\u201352.","journal-title":"J Zhejiang Univ (Medical Sciences)"},{"issue":"2","key":"930_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","volume":"75","author":"YC Zhao","year":"2020","unstructured":"Zhao YC, Zhao GJ, Chen Z, She Z, Cai J, Li H. Nonalcoholic fatty liver disease: an emerging driver of hypertension. Hypertension. 2020;75(2):275\u201384.","journal-title":"Hypertension"},{"issue":"5","key":"930_CR30","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jhep.2014.01.009","volume":"60","author":"KC Sung","year":"2014","unstructured":"Sung KC, Wild SH, Byrne CD. Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension. J Hepatol. 2014;60(5):1040\u20135.","journal-title":"J Hepatol"},{"issue":"4","key":"930_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/MEG.0000000000002299","volume":"34","author":"S Ciardullo","year":"2022","unstructured":"Ciardullo S, Grassi G, Mancia G, Perseghin G. Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2022;34(4):365\u201371.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"930_CR32","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa112","volume":"105","author":"B Wang","year":"2020","unstructured":"Wang B, Li M, Zhao Z, Wang S, Lu J, Chen Y, et al. Glycemic measures and development and resolution of nonalcoholic fatty liver disease in nondiabetic individuals. J Clin Endocrinol Metab. 2020;105(5): dgaa112.","journal-title":"J Clin Endocrinol Metab"},{"key":"930_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fendo.2020.00179","volume":"11","author":"F Wei","year":"2020","unstructured":"Wei F, Li J, Chen C, Zhang K, Cao L, Wang X, et al. Higher serum uric acid level predicts non-alcoholic fatty liver disease: a 4-year prospective cohort study. Front Endocrinol (Lausanne). 2020;11:179.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"930_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.14309\/ajg.0000000000001030","volume":"116","author":"G Yamada","year":"2021","unstructured":"Yamada G, Hagiwara Y, Kimura T, Takeuchi Y, Oba K, Masuda K, et al. Impact of body weight gain on the incidence of nonalcoholic fatty liver disease in nonobese Japanese individuals. Am J Gastroenterol. 2021;116(4):733\u201340.","journal-title":"Am J Gastroenterol"},{"key":"930_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.637241","volume":"8","author":"JH Rim","year":"2021","unstructured":"Rim JH, Youk T, Gee HY, Cho J, Yoo J. Dynamic chronological changes in serum triglycerides are associated with the time point for non-alcoholic fatty liver disease development in the nationwide korean population cohort. Front Med (Lausanne). 2021;8: 637241.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"930_CR36","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.dld.2021.02.010","volume":"53","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Ballabeni C, Trevisan R, Perseghin G. Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population. Dig Liver Dis. 2021;53(7):866\u201372.","journal-title":"Dig Liver Dis"},{"key":"930_CR37","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, Fan J, Kawaguchi T, Ahn SH, et al. The Asian Pacific association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14:889\u2013919.","journal-title":"Hepatol Int"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-022-00930-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-022-00930-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-022-00930-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T14:09:20Z","timestamp":1669644560000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-022-00930-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["930"],"URL":"https:\/\/doi.org\/10.1186\/s13098-022-00930-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"15 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of the First Affiliated Hospital of Sun Yat-sen University and written informed consent was acquired from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}